Infectious disease diagnostic procedures are designed to diagnose and investigate the causative agent of an infectious disease.Increasing global prevalence of infectious diseases, growing awareness for early detection using specific diagnostic tests, growth in funding for research on infectious disease diagnostics, and shift in focus from centralized laboratories to decentralized point-of-care testing are the major factors driving the growth of the infectious disease diagnostics market.
The global infectious disease diagnostics market study presents historical market data in terms of values, estimated current data, and forecasts for 2025-by product (assays and kits, instruments, and software & services), technology (immunodiagnostics, clinical microbiology, Polymerase Chain Reaction (PCR), isothermal nucleic acid amplification technology (INAAT), DNA sequencing & Next-Generation Sequencing (NGS), DNA microarray, and other technologies), disease type (hepatitis, HIV, hospital-acquired infections, HPV, tuberculosis, influenza, and other infectious diseases), end user hospital/clinical laboratories, reference laboratories, academics/research institutes, and other end user). The study also evaluates industry competitors and analyzes the market at regional and country level.
Browse in depth report: https://www.meticulousresearch.com/product/infectious-disease-diagnostics-market-4976/
Table of Contents:
• Research Methodology
• Executive Summary
• Market insights
• Global Infectious Disease Diagnostics Market, by Product and Services
• Global Infectious Disease Diagnostics Market, by Technology
• Global Infectious Disease Diagnostics Market, by Disease Type
• Global Infectious Disease Diagnostics Market, by End User
• Infectious Disease Diagnostics Market, by Region
• Competitive Landscape
• Company Profiles (Includes Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)
Request sample report on: https://www.meticulousresearch.com/request-sample-report/cp_id=4976
Asia Pacific region is expected to be the fastest growing geographic market for infectious disease diagnostics market with countries, such as China, Japan, India and Singapore among others are being the largest contributors to the growth of the market. Additionally, rapid urbanization, increasing investments by healthcare providers towards infrastructure improvement, need to manage growing burden of infectious diseases, and government efforts to improve accessibility of diagnostic services are expected to equally influence the overall growth of the infectious disease diagnostics market during the forecast period.
The major players operating in the global infectious disease diagnostics market are Abbott Laboratories (U.S.), Danaher (U.S.), Bio-Rad Laboratories (U.S.), bioMérieux SA (France), F. Hoffmann-La Roche Ltd (Switzerland), BD (U.S.), DiaSorin S.p.A. (Italy), Meridian Bioscience, Inc. (U.S.), Quidel Corporation (U.S.), and Thermo Fisher Scientific Inc. (U.S.) among others.
The report includes competitive landscape based on extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 4 years (2016-2019). The key players profiled in the global infectious disease diagnostics market research report are Abbott Laboratories (US), Danaher (US), Bio-Rad Laboratories (US), bioMérieux SA (France), F. Hoffmann-La Roche Ltd (Switzerland), BD (US), DiaSorin S.p.A. (Italy), Meridian Bioscience, Inc. (US), Quidel Corporation (US), and Thermo Fisher Scientific Inc. (US) among others.